Medicare plans can now cover Wegovy for patients at risk of heart disease
This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.
by Yuki Noguchi
Mar 22, 2024
2 minutes
Updated March 22, 2024 at 12:18 PM ET
For the first time, Medicare will allow coverage of one of the new blockbuster weight-loss drugs for enrollees in Part D plans.
The plans may now cover Wegovy when prescribed to prevent heart attacks and strokes, according to a new policy issued this week from the
You’re reading a preview, subscribe to read more.
Start your free 30 days